A Circle team at Kyoto University of Kyoto announced the development of a new drug that is highly effective, no pain of the Opiidids.
The researchers have revealed in the results, Monday, in the “process of the national academia of sciences” which drug can be traditional alternative, because of their ability to cause addiction; What makes a more secure choice for patients.
Optium Pain’s options is widely in the medical field to handle the middle pain of severe, especially after the surgeons, or in chronic disease as cancer. These drugs include compounds as morphine, and work influence opium receptors in the nervous system to reduce the feeling of pain.
Although these drugs are a golden standard in terms of effective risks, addiction and psychological inhibitions, in addition to the development of drug breathing on time; This requires the higher doses use to achieve the same effect.
Opium crises in the United States are agberbed, the death number due to excessive doses of these supervised materials in 80 thousand in 2023 only; What the scientific community to intensify efforts to develop safe and effective alternatives.
The opposite lacquers is trade towards the new residence, the new residence, which was called “Adriana.” Objectory “α2b” α2b “and in selectively use of” Apronaline of the body, and plays a role of focus, regulating blood pressure.
The high level of “light adrenaline”, in turn, to stimulate the receptacles (α2a) responsible for the sensation of pain, which distinguish this treatment. To fix this compound, researchers used a advanced technique to examine thousands of chemical compounds; That has led to the first—anti–facility world’s discovery of α2b’s future. The medicine has demonstrated effective in the experiments of the mice, and security studies also shown that there are no disturbing side effects.
Then the clinical experiments were conducted to Kyoto University hospital. The first stage included healthy volunteers, and the security of the drug confirmed, while the second step included patients with POV -Lung cancer. In the properties with the company, in cuores with the company “btb therapeutic”, a start -up company is running out of Kyoto University.
According to the team “, Adrian” is the first non -opium residence in Japan, and can be represented a cindrant of hope only with the interview interviewing.
0 Comments